Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition

Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition

Objectives: This study postulated that antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibition may mitigate vascular endothelial growth factor inhibitor (VEGFi)–mediated increases in blood pressure more effectively than other antihypertensive medications in patients rece...

Full description

Bibliographic Details
Main Authors: Wendy J. Bottinor, MD, MSCI, Megan M. Shuey, PhD, Ali Manouchehri, MD, Eric H. Farber-Eger, BS, Meng Xu, MS, Devika Nair, MD, MSCI, Joe-Elie Salem, MD, PhD, Thomas J. Wang, MD, Evan L. Brittain, MD, MSCI
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:JACC. CardioOncology
Subjects:
cancer
hypertension
renin-angiotensin-aldosterone
vascular endothelial growth factor
VEGF
VEGF inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087319300092

Internet

http://www.sciencedirect.com/science/article/pii/S2666087319300092

Similar Items